Inventor · disambiguated record
Christine M. Tarby
Also filed as: TARBY CHRISTINE M
21 granted patents·11 pending applications·267 citations·filing 1997–2022
94Inventor score
Files withBRISTOL MYERS SQUIBB CO18INNATE TUMOR IMMUNITY INC5ELAN PHARM INC2TEIJIN LTD2BRISTOL MYERS SQUIBB PHARMA CO1
Top patents by PatentIndex Score
32 records- 0194US9273057B2Imidazotriazinecarbonitriles useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Mar 1, 2016·29 cites·15 claims
- 0294US6479492B1Compounds which inhibit leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2000·Granted Nov 12, 2002·41 cites·7 claims
- 0394US6362177B1Cyclic amine derivatives and their use as drugsTEIJIN LTD·Filed 2001·Granted Mar 26, 2002·92 cites·22 claims
- 0487US11344543B2NLRP3 modulatorsINNATE TUMOR IMMUNITY INC·Filed 2018·Granted May 31, 2022·2 cites·25 claims
- 0587US6410566B1Cyclic amine derivatives and their use as drugsTEIJIN LTD·Filed 2001·Granted Jun 25, 2002·24 cites·35 claims
- 0686US11554120B21H-pyrazolo[4,3-d]pyrimidine compounds as toll-like receptor 7 (TLR7) agonists and methods and uses thereforBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Jan 17, 2023·4 cites·13 claims
- 0781US7538215B2Compounds which inhibit leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2005·Granted May 26, 2009·2 cites·4 claims
- 0879US9556178B2Imidazotriazinecarbonitriles useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Jan 31, 2017·3 cites·7 claims
- 0979US8940736B2Imidazotriazinecarbonitriles useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Jan 27, 2015·3 cites·19 claims
- 1075US2023140047A11H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS AND METHODS AND USES THEREFORBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 1173US12171756B2NLRP3 modulatorsINNATE TUMOR IMMUNITY INC·Filed 2022·Granted Dec 24, 2024·0 cites·10 claims
- 1273US6593337B1Tricyclic compounds useful as HIV reverse transcriptase inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2000·Granted Jul 15, 2003·3 cites·53 claims
- 1368US6451842B1Cyclic amine derivatives and their use as drugsDU PONT PHARM CO·Filed 1998·Granted Sep 17, 2002·33 cites·37 claims
- 1462US6844340B2Tricyclic 2-pyrimidone compounds useful as HIV reverse transcriptase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Jan 18, 2005·1 cites·32 claims
- 1561US6686353B1Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonistsTEIJIN INTELLECTUAL PROPERTY C·Filed 1997·Granted Feb 3, 2004·30 cites·18 claims
- 1656US7186830B2Tricyclic 2-pyrimidone compounds useful as HIV reverse transcriptase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Mar 6, 2007·0 cites·11 claims
- 1755US12485123B21H-pyrazolo[4,3-d]pyrimidine compounds as toll-like receptor 7 (TLR7) agonistsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Dec 2, 2025·0 cites·10 claims
- 1854US12391675B2NLRP3 modulatorsINNATE TUMOR IMMUNITY INC·Filed 2020·Granted Aug 19, 2025·0 cites·13 claims
- 1953US2023041738A11H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTSBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 2053US2023122249A11H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTSBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 2153US2023140430A11H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTSBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 2253US2023348468A11H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTSBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 2353US2016108050A1Imidazotriazinecarbonitriles useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Application pending·0 cites
- 2453US2023131192A11H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTSBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 2552US2023127326A1C3-SUBSTITUTED 1H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTSBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 2652US2023144824A11H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTSBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 2752US2023118688A11H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTSBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 2851US12187706B2NLRP3 modulatorsINNATE TUMOR IMMUNITY INC·Filed 2020·Granted Jan 7, 2025·0 cites·18 claims
- 2950US12150937B2NLRP3 modulatorsINNATE TUMOR IMMUNITY INC·Filed 2020·Granted Nov 26, 2024·0 cites·16 claims
- 3050US2004002498A1Tricyclic compounds useful as HIV reverse transcriptase inhibitorsFiled 2003·Application pending·0 cites
- 3144US12037323B2Uracil derivatives as Mer-AXL inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Jul 16, 2024·0 cites·10 claims
- 3230US7125895B1Cyclic amine derivatives and their usesBRISTOL MYERS SQUIBB PHARMA RE·Filed 2000·Granted Oct 24, 2006·0 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when Christine M. Tarby files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →